Malaysia Launches Crucial Vaccination Drive versus Dengue

Dengue fever remains a formidable global health challenge, with over 7 million cases reported worldwide by April 2024, surpassing last year’s total. Malaysia, where dengue is hyper-endemic, has seen a 27% rise in cases and a 50% increase in deaths in the first half of 2024 alone. The lack of a definitive cure or antiviral treatment underscores the importance of prevention, especially as those infected a second time face greater risks. In response to this urgent need, KPJ Damansara Specialist Hospital, in collaboration with Takeda Malaysia Sdn Bhd, launched a dengue vaccination programme on 24 August 2024, coinciding with Malaysia’s 67th Independence Day.

The “Dengue and Merdeka” Awareness Event, inaugurated by Puan Nurul Izzah Anwar, highlighted the importance of continuous efforts in combating dengue. Esteemed speakers emphasized the critical role of the new vaccine, which significantly reduces the risk of dengue and hospitalisation. The event also featured educational booths, community engagement activities, and performances, fostering a sense of unity in the fight against dengue. KPJ Damansara’s commitment to public health education is evident as they offer the vaccine at an accessible price, reinforcing the need for proactive health measures.

KPJ announced that the vaccine package starts at RM 220, with a special combo price available at RM 400. For more information, visit https://www.kpjhealth.com.my/damansara/packages/dangue-vaccine-package.

Tags: dengue, Dengue fever, featured, MJN enews, vaccination

Category: MJN enews